History
  • No items yet
midpage
Senju Pharmaceutical Co. v. Apotex Inc.
891 F. Supp. 2d 656
D. Del.
2012
Read the full case

Background

  • Senju and Kyorin co-own the '045 patent; Allergan is the exclusive ophthalmic licensee.
  • This action concerns infringement allegations based on the same ANDA filed in the first litigation.
  • Plaintiffs claim infringement of newly added/amended reexamined claims 6 and 12-16.
  • Reexamination occurred before final judgment in the first litigation and added claims 12-16 and amended claim 6.
  • Defendants move to dismiss under the claim preclusion doctrine, arguing this suit is barred by the prior final judgment.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether claim preclusion bars the current suit Plaintiffs contend new reexamined claims are not barred Defendants argue reexamined claims are barred as a same-action under preclusion Yes; claim preclusion applies to the reexamined claims
Whether the accused product is the same for purposes of preclusion Product remains essentially the same as in the first litigation Product is the same based on public record and ANDA Yes; product is essentially the same for preclusion
Whether reexamination creates a new cause of action Reexamined claims are new and could create new action Reexamination does not yield a new patent or broader claims No; reexamination does not create a new action
What law governs the claim-preclusion analysis in patent cases Regional law governs preclusion, with federal law on unique reexamined claims Federal Circuit law governs the element of same-claim in patent context Federal Circuit law governs the issue of same cause of action; regional law guides general preclusion doctrine

Key Cases Cited

  • Aspex Eyewear, Inc. v. Marchon Eyewear, Inc., 672 F.3d 1335 (Fed.Cir.2012) (reexamination does not create a new patent or new cause of action; claims narrowed but not broader)
  • Acumed LLC v. Stryker Corp., 525 F.3d 1319 (Fed.Cir.2008) (patent-law-specific analysis for same cause of action in infringement cases)
  • Hallco Mfg. Co. v. Foster, 256 F.3d 1290 (Fed.Cir.2001) (engineering the 'same claims' inquiry in patent preclusion)
  • Kearns v. Gen. Motors Corp., 94 F.3d 1553 (Fed.Cir.1996) (independent legal claims per patent grant for preclusion analysis)
  • Abbey v. Mercedes Benz of N. Am., Inc., 138 F. App’x 304 (Fed.Cir.2005) (treatment of patent-related preclusion in appeals)
  • Churchill v. Star Enters., 183 F.3d 184 (3d Cir.1999) (framework for claim preclusion in the Third Circuit)
  • EEOC v. U.S. Steel Corp., 921 F.2d 489 (3d Cir.1990) (duty to conserve judicial resources; preclusion as a policy aim)
  • Migra v. Warren City School District Board of Education, 465 U.S. 75 (U.S. 1984) (distinction between issue and claim preclusion)
Read the full case

Case Details

Case Name: Senju Pharmaceutical Co. v. Apotex Inc.
Court Name: District Court, D. Delaware
Date Published: Sep 17, 2012
Citation: 891 F. Supp. 2d 656
Docket Number: Civil No. 11-1171-SLR
Court Abbreviation: D. Del.